Abstract:Background: Although ductal carcinoma in situ (DCIS) is a non-invasive breast cancer, many DCIS lesions may progress to invasive cancer and the genes and pathways responsible for its progression are largely unknown. FGFR1 plays an important role in cell proliferation, differentiation and carcinogenesis. The purpose of this study is to examine the roles of FGFR1 signaling in gene expression, cell proliferation, tumor growth and progression in a non-invasive DCIS model. Methods: DCIS.COM cells were transfected with an empty vector to generate DCIS-Ctrl cells. DCIS-iFGFR1 cells were transfected with an AP20187-inducible iFGFR1 vector to generate DCIS-iFGFR1 cells. iFGFR1 consists of the v-Src myristoylation membrane-targeting sequence, FGFR1 cytoplasmic domain and the AP20187-inducible FKBP12 dimerization domain, which simulates FGFR1 signaling. The CRISPR/Cas9 system was employed to knockout ERK1, ERK2 or TNFAIP3 in DCIS-iFGFR1 cells. Established cell lines were treated with/without AP20187 and with/without FGFR1, MEK, or ERK1/2 inhibitor. The effects of these treatments were determined by Western blot, RNA-Seq, real-time RT-PCR, cell proliferation, mammosphere growth, xenograft tumor growth, and tumor histopathological assays. Results: Activation of iFGFR1 signaling in DCIS-iFGFR1 cells enhanced ERK1/2 activities, induced partial epithelial-to-mesenchymal transition (EMT) and increased cell proliferation. Activation of iFGFR1 signaling promoted DCIS growth and progression to invasive cancer derived from DCIS-iFGFR1 cells in mice. Activation of iFGFR1 signaling also altered expression levels of 946 genes involved in cell proliferation, migration, cancer pathways, and other molecular and cellular functions. TNFAIP3, a ubiquitin-editing enzyme, is upregulated by iFGFR1 signaling in a FGFR1 kinase activity and in an ERK2-dependent manner. Importantly, TNFAIP3 knockout not only inhibited the AP20187-induced proliferation and tumor growth of DCIS-iFGFR1 cells, but also further reduced baseline proliferation and tumor growth of DCIS-iFGFR1 cells without AP20187 treatment. Conclusions: Activation of iFGFR1 promotes ERK1/2 activity, EMT, cell proliferation, tumor growth, DCIS progression to invasive cancer, and altered the gene expression profile of DCIS-iFGFR1 cells. Activation of iFGFR1 upregulated TNFAIP3 in an ERK2-dependent manner and TNFAIP3 is required for iFGFR1 activation-promoted DCIS.COM cell proliferation, mammosphere growth, tumor growth and progression. These results suggest that TNFAIP3 may be a potential target for inhibiting DCIS growth and progression promoted by FGFR1 signaling.

[The Role of Human Fibroblast Growth Factor Receptor 1-Iiib Isoform in Proliferation of Pancreatic Ductal Cells and Its Effects to Mitogen-Activated Protein Kinase].

The Role of Human Fibroblast Growth Factor Receptor 1-ⅲB Isoform in Pancreatic Cancer Cells

Exon Iii Splicing of Fibroblast Growth Factor Receptor 1 is Modulated by Growth Factors and Cyclin D1

Exon III Splicing of FGF Receptor 1 is Modulated by Growth Factors and Cyclin D1

Regulation of pancreatic cancer cells by fibroblast growth factor receptor-1

PI-3 Kinase Pathway Can Mediate the Effect of TGF-β1 in Inducing the Expression of SHARP-2 in LLC-PK1 Cells

[Effects of IGF-I and BMP-2 Combined Application on Promoting Proliferation, Differentiation and Calcification of MC 3T3-E1 and NIH 3T3 Cells].

[Connective Tissue Growth Factor Promotes the Proliferation of Myofibroblast Through Erk-1/2 Signaling Pathway].

Interactions of Pancreatic Cancer and Stellate Cells Are Mediated by Fgfr1-Iii Isoform Expression

Study on the effects of intestinal trefoil factor on gastric mucosal epithelial cell proliferation and its signal transduction mechanism

Roles of TGFβ1 in the Expression of Phosphoinositide 3-Kinase Isoform Genes and Sensitivity and Response of Lung Telocytes to PI3K Inhibitors

TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K/AKT pathway and EMT

[Transforming Growth Factor-Beta1 Stimulates Matrix Metalloproteinase-9 Production Through ERK Activation Pathway and Upregulation of Ets-1 Protein].

TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells

TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting PI3K/AKT pathway and EMT

Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer

Functions of P38 Mitogen-Activated Protein Kinase Alpha and Beta in Human Pancreatic Cancer Cells

Abstract 3937: Investigating the role of fibulin 3 in pancreatic tumorigenesis

14-3-3 inhibits insulin-like growth factor-I-induced proliferation of cardiac fibroblasts via a phosphatidylinositol 3-kinase-dependent pathway.

Inductive Effect of Transforming Growth Factor Beta1 in Acquiring Neoplastic Stem Cell Ability ;on Pancreatic Cancer Cells

Connective Tissue Growth Factor Induces Transformation of Renal Fibroblasts into Myofibroblasts